Sánchez-Pérez Sònia, Comas-Basté Oriol, Costa-Catala Judit, Iduriaga-Platero Irache, Veciana-Nogués M Teresa, Vidal-Carou M Carmen, Latorre-Moratalla M Luz
Departament de Nutrició, Ciències de l'Alimentació i Gastronomia, Facultat de Farmàcia i Ciències de l'Alimentació, Campus de l'Alimentació de Torribera, Universitat de Barcelona (UB), Santa Coloma de Gramenet, Spain.
Institut de Recerca en Nutrició i Seguretat Alimentària (INSA⋅UB), Universitat de Barcelona (UB), Santa Coloma de Gramenet, Spain.
Front Nutr. 2022 May 25;9:897028. doi: 10.3389/fnut.2022.897028. eCollection 2022.
Nowadays, certain uncertainties related to the onset of histamine adverse effects remain unsolved and still require further research. Questions still to be resolved include the wide range of doses at which dietary histamine may trigger symptoms of intoxication (100-10,000 mg/kg) or the appearance of symptoms of histamine intolerance after the consumption of foods presumable without histamine. It seems feasible that other amines, by acting as competitive substrates, could interfere with histamine degradation by the intestinal enzyme diamine oxidase (DAO). Therefore, the aim of this study was to elucidate the interference of different amines on the rate of histamine degradation by DAO. A series of enzymatic assays were performed using histamine as the reaction substrate combined with different proportions of putrescine, cadaverine, tyramine, spermidine, and spermine (1:0.25, 1:1, 1:4, 1:20). Putrescine and cadaverine significantly delayed histamine degradation at all tested concentrations ( < 0.001). The greatest effect was observed when putrescine or cadaverine concentrations were 20-fold higher than that of histamine, its degradation being reduced by 70 and 80%, respectively, compared to histamine alone (28.16 ± 1.0 mU). In contrast, tyramine, spermidine and spermine significantly inhibited the histamine degradation rate only at the highest concentration (1:20), reducing it by 32-45%. These results demonstrate that other biogenic amines interfere with histamine metabolization by DAO , the extent depending on the substrate. These findings could explain why susceptibility to dietary histamine is so variable and account for the discrepancies in the scientific databases regarding the amount of histamine that triggers adverse health effects.
如今,与组胺不良反应发作相关的某些不确定性仍未解决,仍需进一步研究。有待解决的问题包括膳食组胺可能引发中毒症状的剂量范围(100 - 10,000毫克/千克),或者食用可能不含组胺的食物后出现组胺不耐受症状的情况。其他胺类作为竞争性底物,可能会干扰肠道酶二胺氧化酶(DAO)对组胺的降解,这似乎是可行的。因此,本研究的目的是阐明不同胺类对DAO降解组胺速率的干扰。使用组胺作为反应底物,结合不同比例的腐胺、尸胺、酪胺、亚精胺和精胺(1:0.25、1:1、1:4、1:20)进行了一系列酶促试验。在所有测试浓度下,腐胺和尸胺均显著延迟组胺降解(<0.001)。当腐胺或尸胺浓度比组胺高20倍时,观察到最大影响,与单独的组胺(28.16±1.0 mU)相比,其降解分别减少了70%和80%。相比之下,酪胺、亚精胺和精胺仅在最高浓度(1:20)时显著抑制组胺降解速率,使其降低32 - 45%。这些结果表明,其他生物胺会干扰DAO对组胺的代谢,其程度取决于底物。这些发现可以解释为什么对膳食组胺的易感性如此多变,并解释了科学数据库中关于引发不良健康影响的组胺量的差异。